Featured series 
Tag: Type 1 diabetes
-
Health
Breakthrough within reach for diabetes scientist and patients nearest to his heart
One hundred years after the discovery of insulin, replacement therapy represents “a new kind of medicine,” says Douglas Melton, co-director of Harvard Stem Cell Institute.
-
Health
Improving cell therapy for diabetes
A team of researchers led by Harvard University scientists has improved the laboratory process of converting stem cells into insulin-producing beta cells from 30 percent to 80 percent.
-
Health
Epidemic of autoimmune diseases calls for action
Scientists at the Harvard Stem Cell Institute are seeking ways to protect newly transplanted cells from autoimmune attack.
-
Health
Role of gut bacteria in averting Type 1 diabetes
Study finds guardian gene that protects against Type 1 diabetes and other autoimmune diseases exerts its pancreas-shielding effects by altering the gut microbiota.
-
Health
First area cell transplantation center
An expansive effort by several Harvard-affiliated units and hospitals has created the first cell transplantation center in the Boston area.
-
Science & Tech
Artificial pancreas system aimed at type 1 diabetes mellitus
The University of Virginia School of Medicine and the Harvard John A. Paulson School of Engineering and Applied Sciences have developed an artificial pancreas system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus.
-
Health
Steering stem cell trafficking into pancreas reverses Type 1 diabetes
Harvard researchers at Brigham and Women’s Hospital have uncovered a way to enhance and prolong the therapeutic effects of mesenchymal stem cells in a preclinical model of Type 1 diabetes.
-
Health
Giant leap against diabetes
Harvard stem cell researchers announced a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a disease that affects an estimated 3 million Americans.
-
Health
Potential diabetes breakthrough
Researchers at the Harvard Stem Cell Institute have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated 26 million Americans.
-
Health
Obesity? Diabetes? We’ve been set up
The twin epidemics of obesity and its cousin, diabetes, have been the target of numerous studies at Harvard and its affiliated hospitals and institutions. Harvard researchers have produced a dizzying array of findings on the often related problems.
-
Health
New hope against diabetes
Results from a phase 1 drug trial by Harvard Medical School and Massachusetts General Hospital researchers showed that a decades-old tuberculosis drug knocked out the autoimmune cells that attack diabetic patients’ insulin-producing cells, followed by indications that pancreatic function was improving, albeit transiently.
-
Health
What makes them special
Researchers at Joslin Diabetes Center, a Harvard Medical School affiliate, examine why a select group of long-term type 1 diabetes survivors show so few complications.
